An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease
Clinical trial NCT02566889 · TERMINATED
Trial details
- NCT number
- NCT02566889
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-07-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.